Lauren Santye, Assistant Editor

Ocrelizumab (Ocrevus) granted FDA approval to treat 2 forms of MS.

Novel test demonstrates the benefits of exercise in individuals with neurological injuries and illnesses.

New tuberculosis cases have declined over the past 5 years, but new data show rates are up for TB/HIV coinfections.

Eric Peacock, co-founder and CEO of MyHealthTeams, discusses the importance of specialty pharmacies collaborating with patients in their care.

Neurologist Michael Racke, MD, discusses the new FDA approval of ocrelizumab and how it will impact the future treatment of MS.

Injection helps clear skin and manage itch severity caused by the disease.

Top news of the day from across the health care landscape.

Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.

Findings open the door for new therapeutic options for myelin regeneration in multiple sclerosis.

New report reveals trends in the 8 major markets over the next decade.

Higher physician spending does not equal better outcomes for hospitalized patients.

Top news of the day from across the health care landscape.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.

Safinamide approved as an add-on treatment for patients with Parkinson’s disease when their medications are not working well.

MR-perfusion guided management for stable angina patients is non-inferior compared with invasive angiography and fractional flow reserve.

Genentech’s $100,000 grant will fund a home-based telemedicine program.

Policies targeting both physicians and hospitals could reduce wasteful health care spending.

Study targets wasteful spending in health care.

Jonathan Van Lare, PharmD, director of Clincal Services at Pharmacy Advantage, discusses the elements of a successful specialty pharmacy therapy management program.

National Association of Specialty Pharmacy commissions white paper that explores how direct and indirect remuneration fees affect the specialty pharmacy landscape.

Marker helps differentiate dormant HIV-infected cells from their health counterpart cells.

Clinicians should provide extra attention to patients with heart disease and depression.

Health applications may help younger patients successfully manage type 1 diabetes.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.

Antibody therapy enables efficacious control of HIV-like virus in monkeys.

Need for an increase in HCV testing awareness among health care providers and baby boomers.